FI941048A - Geloniinipolypeptidin koodaavia DNA-sekvenssejä - Google Patents

Geloniinipolypeptidin koodaavia DNA-sekvenssejä Download PDF

Info

Publication number
FI941048A
FI941048A FI941048A FI941048A FI941048A FI 941048 A FI941048 A FI 941048A FI 941048 A FI941048 A FI 941048A FI 941048 A FI941048 A FI 941048A FI 941048 A FI941048 A FI 941048A
Authority
FI
Finland
Prior art keywords
dna sequences
gelonin
sequences encoding
synthetic gene
encoding gelonin
Prior art date
Application number
FI941048A
Other languages
English (en)
Swedish (sv)
Other versions
FI113547B (fi
FI941048A0 (fi
Inventor
Michael G Rosenblum
Kenneth L Beattie
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of FI941048A publication Critical patent/FI941048A/fi
Publication of FI941048A0 publication Critical patent/FI941048A0/fi
Application granted granted Critical
Publication of FI113547B publication Critical patent/FI113547B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817Toxins
    • A61K47/6819Plant toxins
    • A61K47/6825Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
FI941048A 1991-09-06 1994-03-04 Geloniinia koodaava synteettinen geeni ja välineitä ja menetelmiä geenin ja proteiinin tuottamiseksi FI113547B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75594991A 1991-09-06 1991-09-06
US75594991 1991-09-06
PCT/US1992/007066 WO1993005168A1 (en) 1991-09-06 1992-08-21 Dna sequences encoding gelonin polypeptide
US9207066 1992-08-21

Publications (3)

Publication Number Publication Date
FI941048A true FI941048A (fi) 1994-03-04
FI941048A0 FI941048A0 (fi) 1994-03-04
FI113547B FI113547B (fi) 2004-05-14

Family

ID=25041367

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941048A FI113547B (fi) 1991-09-06 1994-03-04 Geloniinia koodaava synteettinen geeni ja välineitä ja menetelmiä geenin ja proteiinin tuottamiseksi

Country Status (18)

Country Link
US (1) US5624827A (fi)
EP (1) EP0602144B1 (fi)
JP (1) JPH06510431A (fi)
KR (1) KR100270195B1 (fi)
CN (1) CN1047402C (fi)
AT (1) ATE173023T1 (fi)
AU (1) AU679427B2 (fi)
CA (1) CA2115049C (fi)
DE (1) DE69227519T2 (fi)
DK (1) DK0602144T3 (fi)
ES (1) ES2123008T3 (fi)
FI (1) FI113547B (fi)
IL (1) IL103057A (fi)
NO (1) NO317659B1 (fi)
NZ (1) NZ244220A (fi)
RU (1) RU2142015C1 (fi)
WO (1) WO1993005168A1 (fi)
ZA (1) ZA926705B (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317009A (en) * 1991-08-26 1994-05-31 New York University Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof
US5837491A (en) * 1991-11-04 1998-11-17 Xoma Corporation Polynucleotides encoding gelonin sequences
US6146850A (en) * 1991-11-04 2000-11-14 Xoma Corporation Proteins encoding gelonin sequences
US5621083A (en) 1991-11-04 1997-04-15 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
US5869619A (en) * 1991-12-13 1999-02-09 Xoma Corporation Modified antibody variable domains
CA2103887C (en) * 1991-12-13 2005-08-30 Gary M. Studnicka Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
JPH08510642A (ja) * 1993-05-12 1996-11-12 ゾマ コーポレイション ゲロニンおよび抗体から成る免疫毒素
US20030166169A1 (en) * 1998-01-16 2003-09-04 Padgett Hal S. Method for constructing viral nucleic acids in a cell-free manner
ZA200305980B (en) 2001-02-12 2007-01-31 Res Dev Foundation Modified proteins, designer toxins, and methods of making thereof
DK1414471T3 (da) 2001-07-17 2012-07-16 Res Dev Foundation Terapeutiske midler omfattende pro-apoptotiske proteiner
AU2003275985A1 (en) * 2002-06-12 2003-12-31 Research Development Foundation Immunotoxin as a therapeutic agent and uses thereof
PT2891666T (pt) 2002-10-16 2017-09-22 Purdue Pharma Lp Anticorpos que se ligam ca 125/0722p associado a células e métodos para a sua utilização
AU2006210769A1 (en) * 2005-02-01 2006-08-10 Research Development Foundation BLyS fusion proteins for targeting BLyS receptor and methods for treatment of B-cell proliferative disorders
KR101224828B1 (ko) * 2009-05-14 2013-01-22 (주)바이오니아 siRNA 접합체 및 그 제조방법
US8759036B2 (en) 2011-03-21 2014-06-24 Affymetrix, Inc. Methods for synthesizing pools of probes
WO2013049227A2 (en) 2011-09-26 2013-04-04 Geneart Ag High efficiency, small volume nucleic acid synthesis
WO2014153188A2 (en) 2013-03-14 2014-09-25 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
EP4029937A1 (en) 2012-10-04 2022-07-20 Research Development Foundation Serine protease molecules and therapies
EP3229959B1 (en) 2014-12-09 2019-05-15 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
EP3359669B1 (en) 2015-10-06 2020-05-13 Pierce Biotechnology, Inc. Devices and methods for producing proteins
US20210147830A1 (en) 2018-06-29 2021-05-20 Thermo Fisher Scientific Geneart Gmbh High throughput assembly of nucleic acid molecules
GB201905303D0 (en) 2019-04-15 2019-05-29 Thermo Fisher Scient Geneart Gmbh Multiplex assembly of nucleic acid molecules
WO2021178809A1 (en) 2020-03-06 2021-09-10 Life Technologies Corporation High sequence fidelity nucleic acid synthesis and assembly
WO2024132094A1 (en) 2022-12-19 2024-06-27 Thermo Fisher Scientific Geneart Gmbh Retrieval of sequence-verified nucleic acid molecules
GB2628173A (en) 2023-03-17 2024-09-18 Thermo Fisher Scient Geneart Gmbh Methods of producing modified nucleic acid sequences for eliminating adverse splicing events

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888415A (en) * 1985-03-04 1989-12-19 Dana-Farber Cancer Institute, Inc. Gelonin immunotoxin
US5024947A (en) * 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby
US5290914A (en) * 1988-04-28 1994-03-01 Mycogen Corporation Hybrid diphtheria-B.t. pesticidal toxins
IE912716A1 (en) * 1990-08-14 1992-02-26 Res Dev Foundation Protein Structure of the Plant Toxin Gelonin

Also Published As

Publication number Publication date
ES2123008T3 (es) 1999-01-01
EP0602144A4 (en) 1995-03-15
NZ244220A (en) 1994-12-22
WO1993005168A1 (en) 1993-03-18
KR100270195B1 (ko) 2001-03-02
RU2142015C1 (ru) 1999-11-27
NO940736D0 (no) 1994-03-03
CN1047402C (zh) 1999-12-15
DE69227519T2 (de) 1999-06-02
EP0602144A1 (en) 1994-06-22
FI113547B (fi) 2004-05-14
EP0602144B1 (en) 1998-11-04
CN1070227A (zh) 1993-03-24
CA2115049A1 (en) 1993-03-18
CA2115049C (en) 2003-10-21
ATE173023T1 (de) 1998-11-15
IL103057A0 (en) 1993-02-21
IL103057A (en) 1999-09-22
ZA926705B (en) 1993-04-28
DE69227519D1 (de) 1998-12-10
DK0602144T3 (da) 1999-07-19
AU679427B2 (en) 1997-07-03
NO317659B1 (no) 2004-11-29
JPH06510431A (ja) 1994-11-24
RU94034733A (ru) 1996-06-10
NO940736L (no) 1994-03-03
FI941048A0 (fi) 1994-03-04
US5624827A (en) 1997-04-29
AU2547692A (en) 1993-04-05

Similar Documents

Publication Publication Date Title
FI941048A (fi) Geloniinipolypeptidin koodaavia DNA-sekvenssejä
IL86480A0 (en) Recombinant dna coding for human proapolipoprotein a-i,expression vectors containing it and cells transformed by said expression vector
AR248044A1 (es) Una secuencia de adn que codifica anticuerpos monoclonales humanizados contra interleuquinas humanas, metodo de obtencion y de seleccion de dichos anticuerpos, vector recombinante y celula huesped.
HK1013847A1 (en) Gdf-1 and uog-1 proteins
DE69434292D1 (de) Für adseverin kodierendes gen
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
ES8708013A1 (es) Procedimiento para preparar plasmidos de expresion prhw11 y prhw12
DE69839178D1 (de) Gene, die für proteine mit transglykolysierungsaktivität kodieren.
NZ241829A (en) Oxalate oxidase, genes encoding it, vectors and transformed plants
FI961202A0 (fi) Grb3-3-geeni, sen variantteja ja niiden käyttöjä
HK1006727A1 (en) Protein structure of the plant toxin gelonin
CO4480058A1 (es) Genes codificantes y procedimiento de expresion de una nueva enzima: ftalil amidasa
ATE304553T1 (de) Polypeptide mit wasserkanalaktivität und dna sequenzen
IT8521507A0 (it) Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni.
AU7871101A (en) Nucleic acids and proteins showing increased expression dose under salt stress